Income Statement
FENNEC PHARMACEUTICALS INC.
FENC
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
44.64 | 47.54 | 21.25 | 1.54 | - | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
|
Cost of Revenue
|
- | - | 1.26 | 0.09 | - | - | - | - | - | - | - | - | - | - | - |
|
Gross Profit
|
44.64 | 47.54 | 19.99 | 1.45 | - | 0.20 | - | - | - | - | - | - | - | - | - |
|
Operating Expenses
|
50.92 | 44.97 | 32.76 | 24.04 | 17.22 | 18.06 | 13.01 | 10.41 | 6.95 | 2.87 | 1.89 | 2.52 | 1.33 | 1.55 | 1.94 |
|
Research & Development
|
0.25 | 0.31 | 0.06 | 3.53 | 4.98 | 5.11 | 5.61 | 5.01 | 1.94 | 0.47 | 0.26 | 0.36 | 0.60 | 2.08 | 1.49 |
|
Selling, General & Administrative
|
28.29 | 23.05 | 20.59 | 17.72 | 12.24 | 12.95 | 7.40 | 5.40 | 5.02 | 2.40 | 1.63 | 2.52 | 1.33 | 1.55 | 1.94 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-6.28 | 2.57 | -12.77 | -22.59 | -17.22 | -17.86 | -13.01 | -10.41 | -6.95 | -2.87 | -1.89 | -2.52 | -1.33 | -1.55 | -1.94 |
|
Non-Operating Income
|
-3.35 | -2.64 | -3.27 | -1.13 | -0.12 | -0.22 | 0.23 | 0.52 | -0.10 | 0.08 | 1.23 | 0.70 | 3.78 | -1.54 | 8.12 |
|
Interest Income
|
0.79 | 1.68 | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Interest Expense
|
2.08 | 4.07 | - | - | - | - | - | - | - | - | - | - | 0.00 | 0.00 | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - | -0.01 | -0.02 | 0.01 | -0.01 | -0.01 | - | - | - | - | - |
|
Income Before Tax
|
-9.64 | -0.04 | -16.05 | - | - | - | - | - | -7.05 | -2.79 | - | -2.18 | - | - | - |
|
Income Tax Expense
|
0.11 | 0.37 | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-9.74 | -0.44 | -16.05 | -23.71 | -17.35 | -18.11 | -12.78 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.85 | -5.16 | 4.69 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-6.28 | 2.57 | -12.77 | -22.59 | -17.22 | -17.86 | -13.01 | -10.41 | -6.95 | -2.87 | -1.89 | -2.52 | -1.33 | -1.55 | -1.94 |
|
Earnings Per Share (Basic)
|
-0.34 | -0.02 | -0.60 | -0.90 | -0.67 | - | - | - | - | - | -0.06 | -0.22 | 0.06 | -0.21 | 0.20 |
|
Diluted EPS
|
-0.34 | -0.02 | -0.60 | -0.90 | -0.67 | - | - | - | - | - | -0.06 | -0.22 | 0.06 | -0.21 | 0.19 |
|
Weighted Average Shares
|
28.58 | 27.29 | 26.57 | 26.28 | 0.03 | 23.70 | 19.90 | 18.94 | 15.01 | 12.77 | 10.83 | 9.87 | 29.16 | 0.03 | 23.98 |
|
Diluted Weighted Avg Shares
|
28.58 | 27.29 | 26.57 | 26.28 | 0.03 | 23.70 | 19.90 | 18.94 | 15.01 | 12.77 | 10.83 | 9.87 | 31.71 | 0.03 | 24.05 |
|
Comprehensive Income
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |